On Sept. 19, 2025, a panel of the Inquiry Committee approved a consent agreement between BCCNM and the registrant to address concerns that occurred between May and November 2024 related to diversion of narcotics from the workplace for self use and undermining the integrity of medical records to obscure the diversion. The registrant made ready admission to the conduct and disclosed a diagnosed disability with a causal relationship to the practice issues via an independent medical report. Intensive treatment has been completed.
The Inquiry Committee recognizes that nurses and midwives, like any member of the public, may grapple with health issues that may impact their ability to practice safely, competently, and ethically. BCCNM expects that registrants will work only when they are fit to do so and will remove themselves from practise when they are unwell.
In this case, the registrant has agreed to undergo formalized medical monitoring for a minimum period of three years to demonstrate abstinence from substance abuse, and to return to nursing practice with limits on their ability to access and/or handle narcotics (and associated medications) while engaging with their employer's disability office as they continue on their recovery journey. In addition, the registrant will also have limits on their practice, including not working night shifts or overtime, not acting as the nurse-in-charge, not being assigned students. The name of the registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying a registrant or their personal health information respecting the condition that impaired their ability to practice nursing or midwifery.
The Inquiry Committee is satisfied that the terms will protect the public.